Redeye strengthens its positive view of Avensia following a strong Q3, with an EBIT significantly above our expectations. Rather than increasing our long-term assumptions, the strong Q3 raises our short- and mid-term forecasts and the likelihood of Avensia reaching our long-term forecasts of 11-12% EBIT margins.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

Attachments

Avensia - Significant and Fast Results from Cost Cuts

© Modular Finance, source Nordic Press Releases